Authors
Loading...
Mutational profiling study reveals position 105 substitutions drive clavulanic acid and avibactam resistance in class A beta-lactamases, highlighting a critical hotspot for inhibitor design.
Radojković et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: